Last reviewed · How we verify
NCT03032432: DEG
A Dynamic Elastic Garment (DEG) in Patients With Rotator Cuff Tendinopathy
Phase 4 trial testing Dynamic Elastic Garment (DEG) brace in Rotator Cuff Tendinopathy. Withdrawn.
15 February 2019
Quick facts
| Lead sponsor | Loma Linda University |
|---|---|
| Phase | Phase 4 |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Start date | 12 June 2018 |
| Primary completion | 15 February 2019 |
| Estimated completion | 15 February 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Dynamic Elastic Garment (DEG) brace
- Corticosteroid injection
Conditions studied
- Rotator Cuff Tendinopathy — all drugs for Rotator Cuff Tendinopathy →
Sponsor
Loma Linda University
Who can join
Adults 18 to 89, any sex, with Rotator Cuff Tendinopathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to determine if patients with shoulder pain and MRI-confirmed rotator cuff tendinosis, will have their pain and function improved when treated with daily use of a dynamic elastic garment along with a corticosteroid injection, when compared to those patients who receive a corticosteroid injection alone. To our knowledge this is the first study to evaluate the use of a dynamic elastic garment on shoulders. * Group A: Control group, will receive and ultrasound-guided corticosteroid injection alone. * Group B: Intervention, ultrasound-guided corticosteroid injection and scheduled use of a dynamic elastic garment, by IntelliSkin. * Group C: Intervention corticosteroid injection and scheduled use of a Dynamic elastic garment, by AlignMed Posture Shirt 2.0. Up to 60 patients will participate and be randomized in this study, both male and female between the ages of 18 to 89 years of age. Subjects will complete a few forms; SF-36, ASES, Simple Shoulder test, these will take place at the initial visit and Then again at your 4 week and 6 week visit. This is a single center study, investigator initiated. 60 subjects will participate in the study at Loma Linda University.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
An Evaluation of the Rotator Cuff Repair Research Pipeline.
Checketts JX, Scott J, Gordon J, Jones J, et al · · 2018 · cited 9× · PMID 30480012 · DOI 10.1177/2325967118805731
Verify or expand the search:
- PubMed search for NCT03032432
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Rotator Cuff Tendinopathy
Currently open trials in the same condition.
- NCT06809543 — Clinical Benefits and Safety of Tropho Tend in the Management of Painful Rotator Cuff Tendinopathy · NA · recruiting
- NCT06517680 — Tight Control for Rotator Cuff Tendinopathy · NA · recruiting
- NCT07164625 — Telerehabilitation vs. In-person Physiotherapy in Young Elite Baseball Players · NA · active not recruiting
Other Loma Linda University trials
Trials by the same sponsor.
- NCT07213843 — Combined Circulatory and Dietary Interventions for Neuropathy · NA · not yet recruiting
- NCT07130812 — Blood Flow Restriction Training as a Targeted Intervention for Rowers With Back Pain. · NA · recruiting
- NCT06673342 — Effectiveness of a Nutritional Counseling Tool in Reducing the Amount and Frequency of Sugar Intake · NA · completed
- NCT06445842 — Short-term Circuit Training on Muscle Mass and Quality of Life in Sedentary Postmenopausal Women · NA · recruiting
- NCT07396831 — Necessity of Post-operative Eye Drops · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03032432 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Loma Linda University
- Last refreshed: 4 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03032432.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing